tiprankstipranks
Trending News
More News >
T2 Biosystems (TTOO)
OTHER OTC:TTOO
US Market

T2 Biosystems (TTOO) Ratios

Compare
2,246 Followers

T2 Biosystems Ratios

TTOO's free cash flow for Q3 2024 was $-1.07. For the 2024 fiscal year, TTOO's free cash flow was decreased by $ and operating cash flow was $-4.91. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
0.40 1.85 3.80 5.47 0.31
Quick Ratio
0.24 1.43 3.46 5.10 0.25
Cash Ratio
0.09 0.98 1.90 1.71 0.18
Solvency Ratio
-0.64 -0.82 -0.69 -0.65 -0.95
Operating Cash Flow Ratio
-0.63 -4.82 -3.33 -4.41 -0.75
Short-Term Operating Cash Flow Coverage
-1.30 -37.45 0.00 0.00 -1.06
Net Current Asset Value
$ -20.01M$ -54.94M$ -29.05M$ -16.77M$ -43.60M
Leverage Ratios
Debt-to-Assets Ratio
1.05 1.72 0.94 0.71 1.57
Debt-to-Equity Ratio
-1.62 -1.48 -4.43 6.39 -1.32
Debt-to-Capital Ratio
2.62 3.08 1.29 0.86 4.16
Long-Term Debt-to-Capital Ratio
0.00 5.13 1.37 0.84 0.00
Financial Leverage Ratio
-1.54 -0.86 -4.69 9.06 -0.84
Debt Service Coverage Ratio
-1.42 -7.56 -6.89 -7.43 -1.04
Interest Coverage Ratio
-23.27 -9.12 -6.52 -7.51 -7.08
Debt to Market Cap
35.42 7.04 0.58 0.30 0.81
Interest Debt Per Share
1.11 1.28K 2.01K 2.53K 5.73K
Net Debt to EBITDA
-0.93 -0.89 -0.85 -1.01 -0.70
Profitability Margins
Gross Profit Margin
-72.57%5.23%26.21%-17.37%-101.12%
EBIT Margin
-463.09%-250.70%-155.62%-227.69%-623.17%
EBITDA Margin
-460.02%-247.46%-146.58%-212.28%-579.47%
Operating Profit Margin
-501.30%-248.87%-153.16%-228.11%-624.57%
Pretax Profit Margin
-484.63%-279.39%-175.50%-258.12%-707.93%
Net Profit Margin
-484.63%-284.11%-190.66%-271.42%-757.19%
Continuous Operations Profit Margin
-484.63%-277.98%-175.50%-258.12%-707.93%
Net Income Per EBT
100.00%101.69%108.64%105.15%106.96%
EBT Per EBIT
96.68%112.26%114.59%113.16%113.35%
Return on Assets (ROA)
-105.52%-184.26%-88.36%-62.23%-221.55%
Return on Equity (ROE)
216.72%158.55%414.59%-563.92%185.60%
Return on Capital Employed (ROCE)
310.66%-232.41%-87.97%-59.70%162.25%
Return on Invested Capital (ROIC)
-270.62%-212.30%-93.32%-61.74%-435.04%
Return on Tangible Assets
-105.52%-184.26%-88.36%-62.23%-221.55%
Earnings Yield
-8886.35%-874.98%-65.26%-32.71%-118.53%
Efficiency Ratios
Receivables Turnover
1.94 10.31 5.47 3.56 2.95
Payables Turnover
1.61 16.31 7.31 10.34 4.47
Inventory Turnover
1.78 4.86 5.30 5.85 4.66
Fixed Asset Turnover
0.51 1.68 1.94 1.22 0.91
Asset Turnover
0.22 0.65 0.46 0.23 0.29
Working Capital Turnover Ratio
-0.34 1.07 0.73 17.21 -0.45
Cash Conversion Cycle
167.80 88.11 85.77 129.72 120.36
Days of Sales Outstanding
188.48 35.40 66.79 102.65 123.71
Days of Inventory Outstanding
205.49 75.09 68.92 62.37 78.37
Days of Payables Outstanding
226.18 22.38 49.93 35.30 81.72
Operating Cycle
393.97 110.49 135.70 165.02 202.08
Cash Flow Ratios
Operating Cash Flow Per Share
-0.87 -992.67 -1.22K -1.78K -4.98K
Free Cash Flow Per Share
-0.87 -999.31 -1.24K -1.81K -5.07K
CapEx Per Share
0.00 6.65 14.48 33.13 83.61
Free Cash Flow to Operating Cash Flow
1.00 1.01 1.01 1.02 1.02
Dividend Paid and CapEx Coverage Ratio
0.00 -149.35 -84.51 -53.75 -59.61
Capital Expenditure Coverage Ratio
0.00 -149.35 -84.51 -53.75 -59.61
Operating Cash Flow Coverage Ratio
-0.82 -0.85 -0.68 -0.77 -1.01
Operating Cash Flow to Sales Ratio
-3.94 -2.27 -1.39 -2.38 -5.44
Free Cash Flow Yield
-4603.54%-703.74%-47.98%-29.26%-86.62%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.01 -0.11 -1.53 -3.06 -0.84
Price-to-Sales (P/S) Ratio
0.09 0.32 2.92 8.30 6.39
Price-to-Book (P/B) Ratio
-0.02 -0.18 -6.35 17.24 -1.57
Price-to-Free Cash Flow (P/FCF) Ratio
-0.02 -0.14 -2.08 -3.42 -1.15
Price-to-Operating Cash Flow Ratio
-0.01 -0.14 -2.11 -3.48 -1.17
Price-to-Earnings Growth (PEG) Ratio
>-0.01 <0.01 0.09 0.04 >-0.01
Price-to-Fair Value
-0.02 -0.18 -6.35 17.24 -1.57
Enterprise Value Multiple
-0.95 -1.02 -2.84 -4.92 -1.80
Enterprise Value
17.20M 56.13M 116.88M 189.42M 86.99M
EV to EBITDA
-0.95 -1.02 -2.84 -4.92 -1.80
EV to Sales
4.37 2.52 4.17 10.45 10.44
EV to Free Cash Flow
-1.11 -1.10 -2.97 -4.30 -1.89
EV to Operating Cash Flow
-1.11 -1.11 -3.01 -4.38 -1.92
Tangible Book Value Per Share
-0.65 -783.66 -406.11 359.60 -3.74K
Shareholders’ Equity Per Share
-0.65 -783.66 -406.11 359.60 -3.74K
Tax and Other Ratios
Effective Tax Rate
0.00 -0.02 -0.09 -0.05 -0.07
Revenue Per Share
0.22 437.33 883.10 747.14 915.78
Net Income Per Share
-1.07 -1.24K -1.68K -2.03K -6.93K
Tax Burden
1.00 1.02 1.09 1.05 1.07
Interest Burden
1.05 1.11 1.13 1.13 1.14
Research & Development to Revenue
1.53 1.16 0.78 0.93 1.96
SG&A to Revenue
0.00 1.37 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.10 0.29 0.25 0.22 0.65
Income Quality
0.81 0.82 0.79 0.92 0.77
Currency in USD